Research Activities
Participation in governmental and scientific working groups to define and optimize diagnostic, therapeutic, and care pathways (guidelines) in communicable and/or non communicable diseases based on epidemiological evidence.
Evaluation of the effectiveness of a lifestyle intervention program to improve metabolic, cognitive and/or functional performance.
Lifestyle and ICT-based intervention studies in age-specific cohorts for the prevention or for the control of disease progression of neurodegenerative (dementias, Parkinson's disease) and metabolic diseases (type II diabetes, overweight/obesity, and metabolic syndrome), and functional performance (sarcopenia).
Evaluation of the effectiveness of pharmacological intervention programs, including supplements.










